(Q35189292)

7 August 2017

1 reference

title

Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. (English)

1 reference

antiphospholipid syndrome

7 August 2017

main subject

1 reference

7

Y Shoenfeld

1 reference

7 August 2017

Guillermo Ruiz-Irastorza

series ordinal

4

object named as

G Ruiz-Irastorza

1 reference

7 August 2017

2

J Chapman

1 reference

7 August 2017

6

M Khamashta

1 reference

7 August 2017

Ronald H. W. M. Derksen

series ordinal

5

object named as

R H W M Derksen

1 reference

7 August 2017

R L Brey

1

1 reference

7 August 2017

S R Levine

series ordinal

3

1 reference

7 August 2017

publication date

1 January 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

12

1 reference

7 August 2017

issue

7

1 reference

7 August 2017

page(s)

508-513

1 reference

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Antibodies against phospholipids other than cardiolipin: potential roles for both phospholipid and protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

The pathogenic role of anti-phosphatidylserine antibodies: active immunization with the antibodies leads to the induction of antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Cerebrovascular ischemic events with high positive anticardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Antiphospholipid antibodies and stroke in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Anticardiolipin antibodies in ischemic stroke in the young: Indian experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Prospective study of anticardiolipin antibodies in stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Importance of serum anticardiolipin antibody levels in coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Anticardiolipin antibodies in ischaemic heart disease: marker or myth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Detection of cerebral microembolic signals by transcranial Doppler may be a useful part of the equation in determining stroke risk in patients with antiphospholipid antibody syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Cerebral microemboli in patients with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Evidence for endothelial injury as the primary event

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Systemic lupus erythematosus complicated by thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Increased immunoglobulin binding to cerebral endothelium in patients with antiphospholipid antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Reactivity patterns of antiphospholipid antibodies and endothelial cells: effect of antiendothelial antibodies on cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU390OA

10.1191/0961203303LU390OA

21 January 2018

Identifiers

DOI

1 reference

release_dkpjmjey3jc55cj36rwabefmky

7 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dkpjmjey3jc55cj36rwabefmky

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference